Status:
COMPLETED
Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Baxter Healthcare Corporation
Conditions:
Mass Casualty Incident
Dehydration
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The study's overarching aim is to determine whether Enzymatically Augmented Subcutaneous Infusion (EASI) can assist in out-of-hospital situations characterized by mismatch between need for, and abilit...
Detailed Description
Background Challenges to IV access outside the hospital The out-of-hospital setting can pose myriad challenges to the provider attempting to gain access to the intravascular compartment. In an individ...
Eligibility Criteria
Inclusion
- Adults participating in disaster medicine drill
Exclusion
- Diabetes
- Allergy to hyaluronidase or its components
- High doses of estrogens
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00386386
Start Date
May 1 2007
End Date
December 1 2007
Last Update
March 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114